Jianling Xie

17PUBLICATIONS
40CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 15, 2026
PDIA1 promotes androgen receptor activation and prostate cancer cell survival through enhancing HMMR stability.

|Jun 02, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

|Mar 20, 2026
PRSS22 inhibits HMOX1-mediated ferroptosis and induces osteopontin cleavage to promote M2 macrophage polarization and colitis-associated carcinogenesis.

Zijian Kuang, Qiliang Su, Wenken Liang

|Oct 14, 2025
Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival.

Jianling Xie, Kaikai Shen, Wenken Liang

|Jan 25, 2025
Cellular Signaling of Amino Acid Metabolism in Prostate Cancer.

Ping Yao, Shiqi Cao, Ziang Zhu

|Oct 25, 2024
Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman, Muhammed H Rahaman, Adrienne R Hanson

Pageof 3

Frequent Collaborators

5 joint publications

Luke A Selth

5 joint publications

Lisa M Butler

3 joint publications

Zijian Kuang

3 joint publications

Christopher G Proud